The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation-Reference-Cited by-同舟云学术

The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation

Published:2009-09 Issue:13 Volume:45 Page:2425-2438
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Carlisi Daniela,Lauricella Marianna,D’Anneo Antonella,Emanuele Sonia,Angileri Liliana,Fazio Pietro Di,Santulli Andrea,Vento Renza,Tesoriere Giovanni

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference50 articles.

1. TRAIL signalling: decisions between life and death;Falschlehner;Int J Biochem Cell Biol,2007

2. Expression of TRAIL and TRAIL receptors in normal and malignant tissues;Daniels;Cell Res,2005

3. Following a TRAIL: update on a ligand and its five receptors;Kimberley;Cell Res,2004

4. Biochemical analysis of the native TRAIL death-inducing signaling complex;Walczak;Meth Mol Biol,2008

5. Caspase activation: the induced-proximity model;Salvesen;Proc Natl Acad Sci USA,1999

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acquired Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Resistance of Human Colorectal Cancer Cells Is Linked to Histone Acetylation and Is Synergistically Ameliorated by Combination with HDAC Inhibitors;Digestive Diseases and Sciences;2024-08-01

2. A molecular subtype model of ccRCC based on immune-related genes for predicting immunotherapy response;2024-04-05

3. Suberoylanilide hydroxamic acid upregulates reticulophagy receptor expression and promotes cell death in hepatocellular carcinoma cells;World Journal of Gastroenterology;2023-09-14

4. The Synergistic Antitumor Effect of Decitabine and Vorinostat Combination on HepG2 Human Hepatocellular Carcinoma Cell Line via Epigenetic Modulation of Autophagy–Apoptosis Molecular Crosstalk;Current Issues in Molecular Biology;2023-07-16

5. HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases;Translational Oncology;2022-02